What is MiniMed Group 's CGM — net sales?

MiniMed Group (MMED) reported CGM — net sales of $390M in Q1 2026.

What does CGM — net sales mean?

This metric represents the total revenue generated from the sale of continuous glucose monitoring hardware, sensors, and associated digital monitoring subscriptions. It serves as a key indicator of market adoption for real-time glucose tracking technology within the diabetes management portfolio. Growth in this segment reflects the company's ability to capture market share in the shift toward automated and data-driven patient care solutions.

MiniMed Group MMED CGM — Net Sales

Other product segments

Consumables

$244M+14.6%

Pumps

$151M+11.0%

Similar metrics at other companies

AMEEMG — Net Sales

$663.9M+12.9%

IRTCCMS — Revenue, net

$51.39M+34.8%

ABTMedical Devices — Net Sales

$5.54B+13.2%

BSXCardiac Rhythm Management — Net Sales

$578M0.0%

MDTDiabetes Group — Net Sales

$838M+15.1%

SMGGrowing media — Net Sales

$23.5M+1.3%

Other financials

Income statement

See full

Revenue$790.0M+15.0%

Gross profit$362.0M-8.4%

Operating income-$100.0M-576%

Net income-$119.0M-1,090%

EPS (diluted)-$0.47-1,075%

Balance sheet

See full

Cash & equivalents$10.0M0.0%

Total debt$61.0M—

Total equity$3.5B-0.7%

Total assets$4.3B—

Cash flow

See full

Operating cash flow-$27.0M-147%

CapEx$167.0M+22.8%

Free cash flow-$194.0M-146%

Valuation

See full

Market cap$4.15B—

Enterprise value$4.2B—

Returns & leverage

See full

Return on equity-4.3%—

Debt / equity0×—

Current ratio1.6×—

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: MiniMed Group ’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiniMed Group 's cgm — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MiniMed Group 's CGM — net sales?: MiniMed Group (MMED) reported CGM — net sales of $390M in Q1 2026.
What does CGM — net sales mean?: This metric represents the total revenue generated from the sale of continuous glucose monitoring hardware, sensors, and associated digital monitoring subscriptions. It serves as a key indicator of market adoption for real-time glucose tracking technology within the diabetes management portfolio. Growth in this segment reflects the company's ability to capture market share in the shift toward automated and data-driven patient care solutions.